|
Printable version |
From: | "hugh webber" <hugh.webber@clear.net.nz> |
Date: | Fri, 16 Feb 2001 06:30:37 +1300 |
you won't now, mate, its failed. See Bloomberg this morning. ---------- > From: Derek <dkw@paradise.net.nz> > To: sharechat@sharechat.co.nz > Subject: [sharechat] Genesis > Date: Thursday, 15 February 2001 19:48 > > Did the market really only give a 3% discount to the GEN share price for > uncertainty over clinical trials of their psoriasis treatment. > > This seems remarkably low and is difficult to understand. > > Would I pay 3% more for a Biotech company after much of the uncertainty > over clinical trials of one of their main products has been removed. > > You bet. > > Derek > > > > > ---------------------------------------------------------------------------- > http://www.sharechat.co.nz/ New Zealand's home for market investors > http://www.netbroker.co.nz/ Trade on Credit, Low Brokerage. Join now. > ---------------------------------------------------------------------------- > To remove yourself from this list, please use the form at > http://www.sharechat.co.nz/forum.shtml. ---------------------------------------------------------------------------- http://www.sharechat.co.nz/ New Zealand's home for market investors http://www.netbroker.co.nz/ Trade on Credit, Low Brokerage. Join now. ---------------------------------------------------------------------------- To remove yourself from this list, please use the form at http://www.sharechat.co.nz/forum.shtml.
Replies
|